Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)
Public ClinicalTrials.gov record NCT06225414. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Hispanic/Latinx community (hereafter Hispanic) is the country's second-largest racial/ethnic group, accounting for 19.1% of the total population. However, they remain one of the most underserved populations with suboptimal access to healthcare and screening services due to low income, lack of health insurance, perceived discrimination, language barriers, and limited health literacy. Lung cancer is the leading cause of cancer related mortality with 1.8 million annual deaths worldwide, with Hispanic patients known to have lower survival rates compared with non-Hispanic whites. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases this mortality rate of lung cancer by 20%. Yet many Latinx patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test and compare the effect of a multi-level intervention on ordering LDCT within 4 months after patient enrollment to those in an Enhanced Usual Care. Our proposed intervention includes: * Primary care provider notifications of patients' LCS eligibility; * Patients' education; * Patients' referral to financial navigation resources; * Patients' reminder to discuss LCS during primary care provider (PCP) visit.
Study identification
- NCT ID
- NCT06225414
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 60 participants
Conditions and interventions
Conditions
Interventions
- Usual Care Other
- Brief Patient Education Behavioral
- Patient education Behavioral
- Referral to financial navigation resources Behavioral
- Patient Reminders Behavioral
- Provider Reminders Behavioral
Other · Behavioral
Eligibility (public fields only)
- Age range
- 50 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 11, 2024
- Primary completion
- Dec 10, 2025
- Completion
- Feb 10, 2026
- Last update posted
- Mar 29, 2026
2024 – 2026
United States locations
- U.S. sites
- 10
- U.S. states
- 1
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCI Health Family Health Center - Anaheim | Anaheim | California | 92801 | — |
| UCI Health-Costa Mesa | Costa Mesa | California | 92627 | — |
| UCI Health-Irvine | Irvine | California | 92612 | — |
| UCI Health-Laguna hilla | Laguna Hills | California | 92653 | — |
| UCI Health-Newport | Newport Beach | California | 92660 | — |
| UCI Health SeniorHealth Center -Pavillion 4 | Orange | California | 92868 | — |
| UCI Medical Center, Pavilion 3 | Orange | California | 92868 | — |
| UCI Health Family Health Center - Santa Ana | Santa Ana | California | 92701 | — |
| UCI-Health Tustin | Tustin | California | 92780 | — |
| UCI Health-Yorba Linda | Yorba Linda | California | 92886 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06225414, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06225414 live on ClinicalTrials.gov.